Neochem Bio Solutions Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDChemicals
The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.7%
CONS
- Company has a high debt-to-equity of 1.80x
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.36x)
- Though reporting repeated profits, the company pays out little dividend (0.0%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SOLARINDS | 21410.70 | 97.29 | 193745.54 | 0.05 | 666.37 | 88.98 | 3668.20 | 70.26 | 38.16 | 27.91 |
| PIDILITIND | 1632.00 | 62.71 | 166117.97 | 1.32 | 8835.10 | 1202.86 | 45515.50 | 1112.74 | 32.38 | 26.28 |
| SRF | 2605.00 | 35.72 | 77218.67 | 0.35 | 758.87 | 75.53 | 5033.26 | 34.63 | 14.21 | 24.57 |
| FLUOROCHEM | 4691.60 | 83.80 | 51537.23 | 0.06 | 219.00 | 19.02 | 1588.00 | 23.97 | 9.58 | 26.83 |
| NAVINFLUOR | 8697.20 | 56.51 | 44623.69 | 0.17 | 243.31 | 107.67 | 1045.08 | 44.07 | 21.39 | 34.17 |
| GODREJIND | 1155.90 | 33.12 | 38936.61 | 0.00 | 523.36 | -27.85 | 5448.09 | 22.16 | 10.64 | 12.82 |
| DEEPAKNTR | 1727.25 | 30.08 | 23558.49 | 0.43 | 345.01 | 207.36 | 2577.60 | 36.39 | 11.58 | 20.96 |
| AETHER | 1656.35 | 93.47 | 21984.38 | 0.00 | 62.75 | 33.45 | 326.56 | 27.49 | 11.65 | 31.47 |
| ATUL | 6465.50 | 23.93 | 19035.57 | 0.46 | 253.93 | 91.85 | 1847.95 | 25.03 | 15.05 | 21.41 |
| AARTIIND | 501.75 | 34.27 | 18199.81 | 0.20 | 155.00 | 260.47 | 2387.00 | 42.42 | 6.95 | 16.00 |
| DEEPAKFERT | 1356.30 | 17.46 | 17179.29 | 0.74 | 490.04 | 100.95 | 3256.26 | 22.47 | 12.12 | 25.96 |
| NEOCHEM | 96.10 | 21.23 | 164.53 | 0.00 | — | — | — | — | 27.34 | — |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 48 | 61 | 84 | |
| 44 | 55 | 71 | |
| Operating Profit | 4 | 6 | 13 |
| OPM % | 8.77% | 9.80% | 15.58% |
| 1 | 1 | 2 | |
| Interest | 2 | 3 | 4 |
| Depreciation | 1 | 1 | 1 |
| Profit before Tax | 2 | 3 | 10 |
| Tax % | 29.34% | 32.59% | 24.47% |
| Net Profit | 1 | 2 | 8 |
| EPS | 2.03 | 2.70 | 11.61 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 27%
- Last Year:
- 49%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 5 | 7 | 7 |
| 3 | 5 | 13 | |
| 26 | 32 | 34 | |
| Trade Payables | 13 | 14 | 16 |
| 3 | 6 | 9 | |
| Total Liabilities | 51 | 64 | 79 |
| 15 | 19 | 19 | |
| 15 | 18 | 24 | |
| 0 | 17 | 25 | |
| 21 | 9 | 11 | |
| Total Assets | 51 | 64 | 79 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -0 | 2 | 3 | |
| Cash from Investing | -3 | -8 | -2 |
| Cash from Financing | 4 | 6 | -1 |
| -0 | 0 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | |||
| EPS (₹) | 1.98 | 2.70 | 11.61 |
| Book Value (₹) | 14.84 | 17.98 | 29.59 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 2.41 | 2.59 | 7.77 |
| PROFITABILITY | |||
| Operating Margin % | 10.02% | 9.80% | 15.58% |
| Net Margin % | 2.23% | 2.95% | 9.21% |
| ROE % | 13.33% | 17.96% | 48.82% |
| ROCE % | 10.54% | 14.15% | 27.34% |
| 2.12% | 3.14% | 10.84% | |
| EFFICIENCY | |||
| Debtor Days | 109 | 94 | 92 |
| Inventory Days | 113 | 99 | 91 |
| Payable Days | 157 | 130 | 100 |
| 65 | 63 | 83 | |
| FINANCIAL HEALTH | |||
| Debt to Equity (x) | 3.26x | 2.78x | 1.80x |
| Interest Coverage (x) | 1.72x | 1.90x | 3.93x |
| 1.09x | 1.17x | 1.21x | |
| GROWTH | |||
| Revenue Growth % | 0.00% | 26.89% | 37.66% |
| Operating Profit Growth % | 0.00% | 41.84% | 120.31% |
| Net Profit Growth % | 0.00% | 67.89% | 330.28% |
| 0.00% | 36.48% | 330.28% | |
| VALUATION | |||
| P/E (x) | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 5.79x | 2.80x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for NEOCHEM
Loading news…
AI Stock Analyst
Neochem Bio Solutions Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account